header logo icon.png
  • About Us

  • Advisory Councils & Leadership

  • Gene Therapy 101

  • Our Priorities

  • Resources

  • News

  • Contact

  • More

    Use tab to navigate through the menu items.
    IGT Chairman Erik Paulsen Joins Healthy Future Task Force Treatments Subcommittee Roundtable

    IGT Chairman Erik Paulsen Joins Healthy Future Task Force Treatments Subcommittee Roundtable

    On April 28th, IGT Chairman Paulsen joined leaders in Congress on the Healthy Future Task Force Treatments Subcommittee Roundtable. The...
    A Troubling Policy Proposal

    A Troubling Policy Proposal

    Last week, IGT joined many organizations in expressing concern about a policy proposal that would restrict patients’ access to certain...
    Prioritizing Minority Health

    Prioritizing Minority Health

    By IGT Scientific, Academic & Medical Advisory Council Chair Donna M. Christensen April is National Minority Health Month, an important...
    IGT Statement on the Introduction of the Medicaid VBPs for Patients Act (H.R. 7389)

    IGT Statement on the Introduction of the Medicaid VBPs for Patients Act (H.R. 7389)

    WASHINGTON, DC (April 5, 2022) – Today, the Institute for Gene Therapies (IGT) Chairman Congressman Erik Paulsen issued the following...
    Rare Disease Day Spotlight: Hope for HPP Patients

    Rare Disease Day Spotlight: Hope for HPP Patients

    By Deborah Fowler, President & Founder of Soft Bones Rare Disease Day is a critical awareness day for many patients and families who are...
    Changing the Way We Look at Huntington’s Disease

    Changing the Way We Look at Huntington’s Disease

    By IGT Patient Advocacy Advisory Council Member and Huntington's Disease Patient Advocate Seth Rotberg As we enter the third year of the...
    IGT Statement on CMS Final Rule on Medicaid Value-based Purchasing Arrangements

    IGT Statement on CMS Final Rule on Medicaid Value-based Purchasing Arrangements

    WASHINGTON, DC (November18, 2021) – Today, the Institute for Gene Therapies (IGT) Chairman Congressman Erik Paulsen issued the following...
    IGT Statement on Senate's FY2022 Appropriations Bill

    IGT Statement on Senate's FY2022 Appropriations Bill

    WASHINGTON, DC (August 6, 2021) – Today, the Institute for Gene Therapies (IGT) Chairman Congressman Erik Paulsen issued the following...
    Patient Perspective: Khrystal Davis

    Patient Perspective: Khrystal Davis

    TX RARE works to improve access and health outcomes for nearly three million Texans living with rare diseases. Khrystal Davis, Founder of...
    Howard University’s Dr. Sudha Sharma on the Importance of Addressing Health Inequities

    Howard University’s Dr. Sudha Sharma on the Importance of Addressing Health Inequities

    IGT is proud to have the National Human Genome Center of Howard University as a member of our Scientific, Academic & Medical Council....
    1
    234
    high res logo.png

    The Institute for Gene Therapies advocates for a modernized regulatory and reimbursement framework that encourages the development of transformative gene therapies and promotes patient access. 

    mail icon.png

    info@gene-therapies.org

    twitter icon.png

    @gene_therapies

    LinkedIn.png

    Institute for Gene Therapies

    Get In Touch

    Thank you. Message submitted.

    footer logo icon.png

    IGT. © 2020 All Rights Reserved